// App-Quantinova.ai

158 : Six-Year Retention Rates with Abatacept vs TNF inhibitors in the Treatment of Rheumatoid Arthritis: Experience from the Real-world Rhumadata Clinical Database and Registry

Researchers

Presenter

  • Louis Bessette

Principal Investigators

  • Boulos Haraoui

  • Jean-Pierre Raynauld

  • Diane Sauvageau

  • Angele Turcotte

  • Edith Villeneuve

  • Frederic Massicotte

  • Jacques Brown

  • Louis Coupal

Medical Centers

  • Institut de Rhumatologie, Montreal, QC, Canada

  • Centre de recherche du CHU de Quebec, Universite Laval, Quebec,Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Interferon

Drug/Treatment

  • Adalimumab

  • Infliximab

  • Etanercept

  • CHS-0214

  • Abatacept

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved